To further promote the international development of Cytotherapy and Longevity (CL) and build a more dynamic academic exchange platform, CL has officially launched a recruitment program for Early Career Editorial Board, inviting young scholars who are actively striving and have academic enthusiasm in related fields to join us.
Application Eligibility
1. Hold a PhD degree and conduct research in regenerative medicine, aging biology, or related interdisciplinary fields.
2. Demonstrate a strong track record of research excellence, with at least five publications as first or corresponding author in internationally recognized journals within the past three years.
3. Have experience participating in national research projects.
4. Commitment to the journal's mission and willingness to contribute to its growth with dedication and enthusiasm.
Responsibilities of Early Career Editorial Board
1. Peer Review: Conduct timely, rigorous, and constructive peer reviews at least three manuscripts per year in the professional field each year.
2. Journal Content Construction: Recommend cutting-edge research topics and potential authors, and provide input on any new initiatives of journal development.
3. Journal Promotion: Promote this CL in academic and professional social circles, with a focus on young researchers.
4. Journal Content Development and Academic Activities: Contribute to the identification, selection, and promotion of high-quality thematic content, and actively participate in academic conferences, seminars, and other events organized or co-organized by the journal.
The Rights of Early Career Editorial Board
1. Selected Early Career Editorial Board members will be appointed for a one-year term (renewable).
2. Participate in editorial board meetings and contribute insights, recommendations, and strategic suggestions to support the journal's advancement.
3. Outstanding Early Career Editorial Board members can receive excellent honorary certificates; Priority will be given to being appointed as a journal Editorial Board member during adjustments or changes in the Editorial Board.
4. Receive opportunities for the promotion of research achievements and team accomplishments through the journal's communication platforms and domestic and international media channels, enhancing academic visibility and influence.
5. Gain opportunities to participate in or organize annual meetings, academic forums, webinars, and other scholarly activities hosted by the Editor-in-Chief and Editorial Board.
About the Journal
CL is co-established by the national-level, cross-institutional, and highly integrated Collaborative Innovation Platform of IUR in China in partnership with ICJN Press. With the core mission of "promoting human health and functional longevity through cell therapy," it is committed to advancing collaborative innovation in cell therapy, mechanomedicine, mechanobiology, and the prevention and treatment of degenerative diseases. Covering the entire industry chain of research, including multiple cell types and their mechanobiological regulatory mechanisms, the development and clinical translation of cell therapies targeting multiple frailty - associate diseases, cell culture and process optimization using physical modulation technologies in mechanomedicine, cell function assessment and the application of clinical efficacy data, the development of intelligent mechanobiological intervention technologies and equipment, the development and clinical translation of cell therapies for cancer prevention and treatment and the development and clinical translation of cell therapies for degenerative diseases. It also promotes the translational application of innovative technologies from mechanomedicine, mechanotherapy, biomechanics, and mechanobiology in combined mechano-immunoregenerative therapies.
· Journal Website：https://www.icjn.net/cl
· Editorial Board：https://www.icjn.net/cl/editorial-board
Applications
Please fill in the Application Form to cl@icjn.net with the subject line "CL Early Career Editorial Board Application + Name".
Deadline: 30 October 2026
Selection Process: Application Submission → Evaluation and Review → Notification → Certificate
Welcome to join us!